Daphna Mokady
Chief Scientific Officer at Endogena Therapeutics
Daphna Mokady is a science-innovation and results-driven professional with 15+ years of academic and industry experience in leading research projects in a broad spectrum of biomedical fields, including regenerative medicine, cancer research, neurodegenerative disease modelling, and microbiology. Her versatile experience enables her to promote innovative ideas and lead pioneering research with demonstrated results. Throughout her work, Daphna cultivated a network of successful collaborations with global pharmaceutical companies, top researchers, and key opinion leaders in various fields. She is a passionate advocate of gender equality in STEM and the founder and president of a Toronto-based initiative aimed at promoting women’s careers in all STEM disciplines up to the boardroom.
Daphna holds a PhD in Microbiology from Tel Aviv University and an MSc (summa cum laude) in Genetics from the Hebrew University of Jerusalem.
Visit website: https://endogena.com/#people/#daphna
See also: Endogena Therapeutics - Clinical-stage biotech company focussed on endogenous regenerative medicines
Details last updated 26-Aug-2022